BridgeBio Oncology Therapeutics Inc: JPMorgan cuts target price to $17 from $23
BBOT•JPMorgan cut its target price for BridgeBio Oncology Therapeutics Inc to $17 from $23.
Related News
M2i Global exercises option and agrees to acquire Graphex Technologies
MTWO•
Trading halted in DPU for volatility at 9:48 a.m.
DPU•
AMEX halts WSLS at 24.95
WSLS•
US weekly jobless claims increase, but labor market remains stable
SPY•
ReSource Point of Sale nearly doubles support volume, cuts resolution time with ServiceNow CRM
NOW•